Inhibitory Control Test for the Diagnosis of Minimal Hepatic Encephalopathy

Gastroenterology

Volumn 135, Issue 5, 2008, Pages

  Bajaj, Jasmohan S ^a   Hafeezullah, Muhammad ^b   Franco, Jose ^b   Varma, Rajiv R ^b   Hoffmann, Raymond G ^b   Knox, Joshua F ^b   Hischke, Darrell ^b   Hammeke, Thomas A ^b   Pinkerton, Steven D ^b   Saeian, Kia ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROBIOTIC AGENT; YOGHURT;

ADULT; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; DISEASE EXACERBATION; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; PATIENT EDUCATION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PSYCHOLOGIST; PSYCHOMETRY; ROC CURVE; TEST RETEST RELIABILITY;

EID: 55249108459     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.07.021     Document Type: Article

References (35)

1. Mullen K., Ferenci P., Bass N.M., et al. An algorithm for the management of hepatic encephalopathy. Semin Liv Dis 27 (2007) 32-48
2. Li Y.Y., Nie Y.Q., Sha W.H., et al. Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China. World J Gastroenterol 10 (2004) 2397-2401
3. Das A., Dhiman R.K., Saraswat V.A., et al. Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis. J Gastroenterol Hepatol 16 (2001) 531-535
4. Romero-Gomez M., Boza F., Garcia-Valdecasas M.S., et al. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy. Am J Gastroenterol 96 (2001) 2718-2723
5. Prasad S., Dhiman R.K., Duseja A., et al. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45 (2007) 549-559
6. Wein C., Koch H., Popp B., et al. Minimal hepatic encephalopathy impairs fitness to drive. Hepatology 39 (2004) 739-745
7. Bajaj J.S., Hafeezullah M., Hoffmann R.G., et al. Minimal hepatic encephalopathy: a vehicle for accidents and traffic violations. Am J Gastroenterol 102 (2007) 1903-1909
8. Groeneweg M., Quero J.C., De Bruijn I., et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28 (1998) 45-49
9. Weissenborn K., Ennen J.C., Schomerus H., et al. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34 (2001) 768-773
10. Ford J.M., Gray M., Whitfield S.L., et al. Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 61 (2004) 119-129
11. Schiff S., Vallesi A., Mapelli D., et al. Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study. Metab Brain Dis 20 (2005) 381-392
12. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 35 (2002) 716-721
13. Bajaj J.S., Etemadian A., Hafeezullah M., et al. Testing for minimal hepatic encephalopathy in the United States: an AASLD survey. Hepatology 45 (2007) 833-834
14. Epstein J.N., Johnson D.E., Varia I.M., et al. Neuropsychological assessment of response inhibition in adults with ADHD. J Clin Exp Neuropsychol 23 (2001) 362-371
15. Konrad K., Gauggel S., Manz A., et al. Inhibitory control in children with traumatic brain injury (TBI) and children with attention deficit/hyperactivity disorder (ADHD). Brain Inj 14 (2000) 859-875
16. Garavan H., Ross T.J., and Stein E.A. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A 96 (1999) 8301-8306
17. Pliszka S.R., Liotti M., and Woldorff M.G. Inhibitory control in children with attention-deficit/hyperactivity disorder: event-related potentials identify the processing component and timing of an impaired right-frontal response-inhibition mechanism. Biol Psychiatry 48 (2000) 238-246
18. Ballard J.C. Assessing attention: comparison of response-inhibition and traditional continuous performance tests. J Clin Exp Neuropsychol 23 (2001) 331-350
19. Bajaj J.S., Saeian K., Verber M.D., et al. Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy. Am J Gastroenterol 102 (2007) 754-760
20. Wechsler D. Wechsler Adult Intelligence Scale-III (1999), Psychological Corp, San Antonio, TX
21. Bajaj J.S., Hafeezullah M., Hoffmann R.G., et al. Navigation skill impairment: another dimension of the driving difficulties in minimal hepatic encephalopathy. Hepatology 47 (2008) 596-604
22. Bajaj J.S., Saeian K., Christensen K., et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol 103 (2008) 1707-1715
23. AMA. Current Procedural Terminology (2007), American Medical Association, Chicago, IL
24. Weissenborn K., Giewekemeyer K., Heidenreich S., et al. Attention, memory, and cognitive function in hepatic encephalopathy. Metab Brain Dis 20 (2005) 359-367
25. Walker A.J., Shores E.A., Trollor J.N., et al. Neuropsychological functioning of adults with attention deficit hyperactivity disorder. J Clin Exp Neuropsychol 22 (2000) 115-124
26. Ortiz M., Cordoba J., Jacas C., et al. Neuropsychological abnormalities in cirrhosis include learning impairment. J Hepatol 44 (2006) 104-110
27. Ortiz M., Jacas C., and Cordoba J. Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42 Suppl (2005) S45-S53
28. Perry W., Hilsabeck R.C., and Hassanein T.I. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 53 (2008) 307-321
29. Watanabe A., Sakai T., Sato S., et al. Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy. Hepatology 26 (1997) 1410-1414
30. Sanyal A.J., Freedman A.M., Shiffman M.L., et al. Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study. Hepatology 20 (1994) 46-55
31. Jalan R., Elton R.A., Redhead D.N., et al. Analysis of prognostic variables in the prediction of mortality, shunt failure, variceal rebleeding and encephalopathy following the transjugular intrahepatic portosystemic stent-shunt for variceal haemorrhage. J Hepatol 23 (1995) 123-128
32. Riggio O., Masini A., Efrati C., et al. Pharmacological prophylaxis of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt: a randomized controlled study. J Hepatol 42 (2005) 674-679
33. Mullen K.D., Ghanta R.K., and Putka B.S. Prevention of first overt episode of hepatic encephalopathy after TIPS: no easy task. Hepatology 43 (2006) 1155-1156
34. Liu Q., Duan Z.P., Ha da K., et al. Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39 (2004) 1441-1449
35. Malaguarnera M., Greco F., Barone G., et al. Bifidobacterium longum with fructo-oligosaccharide (FOS) treatment in minimal hepatic encephalopathy: a randomized, double-blind, placebo-controlled study. Dig Dis Sci 52 (2007) 3259-3265